Thomas Helleday PhD

Thomas Helleday is the Torsten and Ragnar Söderberg Professor of Translational Medicine and Chemical Biology at Science for Life Laboratory at the Karolinska Institutet Science Park in Stockholm. Thomas Helleday heads Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet. He has won numerous prestigious prizes including the Carcinogenesis Young Investigator Award 2010, the Swiss Bridge Award 2008 by Swiss Cancer League and the International Union Against Cancer (UICC), the Svedberg Award 2008 by SFBM and Swedish National Committee for Molecular Biosciences, the European Association for Cancer Research Young Cancer Researchers Award 2007, the Royal Swedish Academy of Sciences’ Hilda and Alfred Eriksson’s prize 2007 for an outstanding research contribution in relief of diseases in man or animal, British Association for Cancer Research (BACR) - AstraZeneca Young Scientist Frank Rose Award 2006, the Eppendorf-Nature Young European Investigator Award 2005 for outstanding contribution within the field of biomedical science and the European Environmental Mutagen Society (EEMS) Young Scientist Award 2005. The current focus in the Helleday laboratories is understanding and exploiting DNA repair and DNA-damage signalling pathways at replication forks for novel anti-cancer therapies.